Opus Genetics, Inc. Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31)
Opus Genetics, Inc. (IRD) had Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) of $2.34 thousand as of 2010-12-31, per its 10-K filed 2013-03-22.
Discontinued › Notes › Investments
us-gaap:AvailableForSaleSecuritiesGrossUnrealizedLosses1 · last filed 2013-03-22
- 2010-12-31: Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) $2.34K; Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) as first filed -$2.34K.
- 2008-12-31: Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) $550.48K; Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) as first filed -$550.48K.
| Period end | Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) | Available-for-sale Securities, Gross Unrealized Losses (Deprecated 2013-01-31) as first filed |
|---|---|---|
| 2010-12-31 | $2.34K 10-K · filed 2013-03-22 | -$2.34K 10-K · filed 2012-03-16 |
| 2008-12-31 | $550.48K 10-K · filed 2013-03-22 | -$550.48K 10-K · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| GALECTIN THERAPEUTICS INC (GALT) | United States | $0.399B | -11.06 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |